Bookmark and Share

Do Business, Not War

Issued: July 31 2018

Michelle Ko peers into the vast abyss of the China-US trade war, and the complicated considerations that surround it.

 

Related Articles

  • Should My Bioscience Startup Move Out of...
    If your bioscience research has yielded strong results and you have some interest from investors, it may be time to move your IP out of...
  • Case Guidance and Stare Decisis IP Cases
    Reforms in China’s judicial system are slowing taking root. Gang Hu and Xiaomeng Dong explain the significance of these developments an...
  • Cheaper Medicines Law Seeks to Cut Healt...
    While the Cheaper Medicines Law is expected to sharply reduce the cost of pharmaceuticals, failure to strictly follow mechanisms provid...
  • Are We In Wonderland?
    In these times of spiralling litigation and the resultant chronic congestion in courts, the concept of speedy litigation might seem oxy...
  • Chinese Conundrums
    China is gradually bringing its IP legislation up to globally acceptable standards, while the judicial system is taking greater note of...
  • Recent PRB Decisions on Pharma and Biote...
    China’s Patent Reexamination Board plays an important role in determining what can be patented in the country. Jiancheng Jiang examines...